A message from MMV's CEO, David Reddy
As MMV’s 19th year comes to an end, we once again pay tribute to the power of partnerships and collaboration. Once again, as we follow the path outlined by our 5-year Business Plan, MMV’s partnerships have had considerable impact on the lives of people living in malaria-endemic countries that we serve. Our unified efforts to make antimalarials available to the vulnerable continues to save countless lives. In parallel, we continue to progress next-generation medicines through our pipeline with the confidence that these, too, will one day have the same impact.
Details follow in the 2018 review document below.
We send you heartfelt thanks for supporting our work and wish you the very best for 2019.